CNS Pharmaceuticals CNSP
€ 0.12
2.72%
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
CNS Pharmaceuticals Kennzahlen 2011-2024 | CNSP
Kennzahlen Jährlich CNS Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.1 | -0.0 | -3.0 | -15.3 | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-5 | -11.2 | -16.5 | -0.6 | -0.3 | -0.7 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
6.9 M | -3.6 M | -1.88 M | 16.2 M | 52.4 M | 677 K | 221 K | - | - | - | - | - | - |
EBITDA per Share |
-5.01 | -11.2 | -16.5 | -0.573 | -0.281 | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.2 | -1.6 | -13.6 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.02 | -0.38 | - | - | - | - | - | - | - | - | ||
P/B |
-0.3 | 0.2 | 0.1 | 2.0 | 7.8 | - | - | - | - | - | - | - | - |
P/CF |
-0.1 | -0.1 | -0.0 | -3.9 | -16.6 | - | - | - | - | - | - | - | - |
ROE % |
425.33 | -187.81 | -235.19 | -67.81 | -51.01 | - | - | - | - | - | - | - | - |
ROA % |
-1108.34 | -117.02 | -165.52 | -59.66 | -49.00 | - | - | - | - | - | - | - | - |
ROCE % |
425.65 | -187.72 | -235.04 | -67.78 | -50.43 | - | - | - | - | - | - | - | - |
Current Ratio |
0.3 | 2.7 | 3.4 | 8.1 | 25.4 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich CNS Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | -6.72 | -0.41 | - | -54.14 | -51.86 | -2.59 | - | -2.56 | -2.67 | -2.44 | - | -0.14 | -0.15 | -0.15 | - | -0.12 | -0.15 | -0.12 | - | -0.05 | -0.03 | -0.02 | - | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.41 | - | - | - | -2.58 | - | -2.56 | -2.67 | -2.43 | - | -0.14 | -0.15 | -0.15 | - | -0.12 | -0.15 | -0.12 | - | -0.05 | -0.03 | -0.02 | - | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
231.54 | 658.59 | 435.81 | -45.26 | -90.45 | -395.45 | -264.95 | -101.07 | -142.99 | -139.72 | -137.12 | -104.79 | -119.21 | -91.71 | -78.71 | -46.26 | -55.56 | -50.44 | -38.38 | -17.76 | 17.41 | 61.88 | 197.71 | -720.37 | -720.37 | -755.54 | -885.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-585.85 | -704.46 | -664.30 | -323.12 | -358.60 | -199.81 | -166.12 | -83.99 | -117.13 | -114.80 | -112.94 | -87.42 | -100.11 | -79.64 | -68.46 | -40.70 | -49.64 | -45.88 | -35.73 | -17.06 | -45.33 | -64.68 | -59.22 | -28.27 | -28.27 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
231.43 | 659.80 | 436.91 | -44.64 | -89.82 | -395.45 | -264.77 | -101.03 | -142.94 | -139.66 | -137.06 | -104.73 | -119.15 | -91.66 | -78.68 | -46.26 | -55.46 | -50.24 | -37.97 | -17.22 | 13.71 | 53.84 | 59.30 | 30.93 | 30.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.8 | 0.4 | 0.3 | 0.3 | 0.6 | 1.6 | 1.9 | 2.6 | 7.8 | 13.5 | 14.8 | 4.1 | 4.8 | 7.8 | 6.9 | 8.3 | 8.3 | 8.3 | 8.3 | 25.4 | 25.4 | 25.4 | 25.4 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 897.0 | 679.6 | 1886.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | -897.0 | -679.6 | -1886.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung